These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 12529173)

  • 1. The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation.
    Brown SA; Richards CM; Hanscom HN; Feng SL; Winkles JA
    Biochem J; 2003 Apr; 371(Pt 2):395-403. PubMed ID: 12529173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily.
    Galibert L; Tometsko ME; Anderson DM; Cosman D; Dougall WC
    J Biol Chem; 1998 Dec; 273(51):34120-7. PubMed ID: 9852070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
    Saitoh T; Nakayama M; Nakano H; Yagita H; Yamamoto N; Yamaoka S
    J Biol Chem; 2003 Sep; 278(38):36005-12. PubMed ID: 12840022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
    Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
    Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase.
    Hatzoglou A; Roussel J; Bourgeade MF; Rogier E; Madry C; Inoue J; Devergne O; Tsapis A
    J Immunol; 2000 Aug; 165(3):1322-30. PubMed ID: 10903733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
    Morrison MD; Reiley W; Zhang M; Sun SC
    J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
    Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
    J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1.
    Malinin NL; Boldin MP; Kovalenko AV; Wallach D
    Nature; 1997 Feb; 385(6616):540-4. PubMed ID: 9020361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.
    Harada N; Nakayama M; Nakano H; Fukuchi Y; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2002 Dec; 299(3):488-93. PubMed ID: 12445828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
    Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
    Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
    J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase.
    Kim HH; Lee DE; Shin JN; Lee YS; Jeon YM; Chung CH; Ni J; Kwon BS; Lee ZH
    FEBS Lett; 1999 Jan; 443(3):297-302. PubMed ID: 10025951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome.
    Tran NL; McDonough WS; Savitch BA; Fortin SP; Winkles JA; Symons M; Nakada M; Cunliffe HE; Hostetter G; Hoelzinger DB; Rennert JL; Michaelson JS; Burkly LC; Lipinski CA; Loftus JC; Mariani L; Berens ME
    Cancer Res; 2006 Oct; 66(19):9535-42. PubMed ID: 17018610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway.
    Roos C; Wicovsky A; Müller N; Salzmann S; Rosenthal T; Kalthoff H; Trauzold A; Seher A; Henkler F; Kneitz C; Wajant H
    J Immunol; 2010 Aug; 185(3):1593-605. PubMed ID: 20610643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.